Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
JCI Insight
|
September 23, 2025
The receptor BLT1 is essential on neutrophils in a mouse model of mucous membrane pemphigoid
Tabea Bremer, Sripriya Murthy, Sabrina Patzelt, et al.
Plos One
|
November 3, 2021
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
Katharina Boch, Sören Dräger, Detlef Zillikens, et al.
The Journal of Investigative Dermatology
|
May 25, 2021
Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases
Sripriya Murthy, Paul Schilf, Sabrina Patzelt, et al.
The Journal of Investigative Dermatology
|
September 25, 2024
Anti-Laminin β4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin α3 and γ1/2 Chains
Manuela Pigors, Stephanie Goletz, Yao Wang, et al.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Biomolecules
|
March 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo
Gefei Du, Shirin Emtenani, Dennis Niese, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
February 5, 2025
Meeting Report on "10th Anniversary Symposium on Inflammatory Skin Disease"
Shirin Emtenani, John F Baines, Katja Bieber, et al.
The British Journal of Dermatology
|
October 2, 2025
Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study
Sabrina Patzelt, Rengin Melis Engin, Kossara Drenovska, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
JCI Insight
|
September 23, 2025
The receptor BLT1 is essential on neutrophils in a mouse model of mucous membrane pemphigoid
Tabea Bremer, Sripriya Murthy, Sabrina Patzelt, et al.
Plos One
|
November 3, 2021
Immunization with desmoglein 3 induces non-pathogenic autoantibodies in mice
Katharina Boch, Sören Dräger, Detlef Zillikens, et al.
The Journal of Investigative Dermatology
|
May 25, 2021
Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases
Sripriya Murthy, Paul Schilf, Sabrina Patzelt, et al.
The Journal of Investigative Dermatology
|
September 25, 2024
Anti-Laminin β4 IgG Drives Tissue Damage in Anti-p200 Pemphigoid and Shows Interactions with Laminin α3 and γ1/2 Chains
Manuela Pigors, Stephanie Goletz, Yao Wang, et al.
The Journal of Pathology
|
November 6, 2023
Bullous pemphigoid induced by IgG targeting type XVII collagen non-NC16A/NC15A extracellular domains is driven by Fc gamma receptor- and complement-mediated effector mechanisms and is ameliorated by neonatal Fc receptor blockade
Manuela Pigors, Sabrina Patzelt, Niklas Reichhelm, et al.
Frontiers in Immunology
|
October 17, 2022
Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Frontiers in Immunology
|
December 19, 2022
Corrigendum: Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases
Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, et al.
Biomolecules
|
March 28, 2026
Complement Activation May Drive the Pathogenicity of Anti-α6 and Anti-β4 Integrin Antibodies In Vivo
Gefei Du, Shirin Emtenani, Dennis Niese, et al.
JID Innovations : Skin Science From Molecules to Population Health
|
February 5, 2025
Meeting Report on "10th Anniversary Symposium on Inflammatory Skin Disease"
Shirin Emtenani, John F Baines, Katja Bieber, et al.
The British Journal of Dermatology
|
October 2, 2025
Standardized indirect immunofluorescence-based detection of dermal-binding autoantibodies in pemphigoid diseases: a prospective international multicentre study
Sabrina Patzelt, Rengin Melis Engin, Kossara Drenovska, et al.
Page
of 2